EPN-701 (Oral)

DRUG2 trials

Sponsors

Epizon Pharma, Inc., Sagar U. Nigwekar, MD, MMSc

Conditions

CalciphylaxisEnd-Stage Renal Disease (ESRD)

Phase 2

A Clinical Trial of Epizon-701 (EPN-701) in Subjects With End-Stage Renal Disease (ESRD)

CompletedNCT05285787

Epizon Pharma, Inc.End-Stage Renal Disease (ESRD)

Start: 2019-03-01End: 2021-04-30Updated: 2024-09-25

Study of EPN-701 for the Treatment of Calciphylaxis

Not yet recruitingNCT07583745

Sagar U. Nigwekar, MD, MMScCalciphylaxis

Start: 2026-10-01End: 2030-09-30Target: 60Updated: 2026-09-14